Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases). (Q38074212)

28 August 2017

1 reference

title

Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases). (English)

1 reference

28 August 2017

antimicrobial resistance

1 reference

0 references

3

George G Zhanel

1 reference

28 August 2017

Joseph P Lynch

1

1 reference

PubMed ID

23321047

28 August 2017

Nina M Clark

series ordinal

2

1 reference

PubMed ID

23321047

28 August 2017

language of work or name

English

0 references

publication date

15 January 2013

1 reference

Expert Opinion on Pharmacotherapy

28 August 2017

1 reference

28 August 2017

14

1 reference

28 August 2017

2

1 reference

28 August 2017

199-210

1 reference

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

28 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Global spread of Carbapenemase-producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Has the era of untreatable infections arrived?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Long-term clinical and economic benefits associated with the management of a nosocomial outbreak resulting from extended-spectrum beta-lactamase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Genetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Colonization with extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in long-term care facility residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Clinical management of ESBL-producing Enterobacteriaceae: the insidious role of fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a UK district hospital; an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Updated functional classification of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

CTX-M: changing the face of ESBLs in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

High burden of antimicrobial resistance in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

The challenges of antimicrobial resistance in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Trends in antimicrobial resistance in intensive care units in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Molecular epidemiology of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae over a 10 year period in Calgary, Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Multicenter antimicrobial susceptibility survey of gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Community-acquired extended-spectrum beta-lactamase producers, United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

The latest threat in the war on antimicrobial resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Importation of KPC-2-producing Escherichia coli from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Early dissemination of KPC-2-producing Klebsiella pneumoniae strains in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 Carbapenemase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

KPC-2-producing sequence type 11 Klebsiella pneumoniae detected in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Klebsiella pneumoniae Carbapenemase-producing enterobacteria in hospital, Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Spread of OXA-48-encoding plasmid in Turkey and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria, Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

bla(OXA-181)-positive Klebsiella pneumoniae, Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of New Delhi metallo-β-lactamase, Austria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Global spread of New Delhi metallo-β-lactamase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Identification of NDM-1-producing Enterobacteriaceae in Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of an autochthonous and community-acquired NDM-1-producing Klebsiella pneumoniae in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Detection of NDM-1-producing Klebsiella pneumoniae in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

NDM-1--a cause for worldwide concern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Emergence of NDM-1-producing Acinetobacter baumannii in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

NDM-2 carbapenemase in Acinetobacter baumannii from Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 200

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Global spread of New Delhi metallo-β-lactamase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

Plasmid-mediated carbapenem-hydrolysing OXA-48 β-lactamase in Klebsiella pneumoniae from Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.763030

10.1517/14656566.2013.763030

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23321047